Biotechnology

Pharmaceuticals Biotechnology Obesity Drug Development Partnerships Pharmaceutical Investments Public Companies Grants Funding Biopharmaceuticals

5 ARTICLES

2w ago

Samsung Biologics Announces Spin-Off of Biosimilar Unit to Form Samsung Epis Holdings

The restructuring aims to sharpen strategic focus, address client concerns, and enhance shareholder value with a clear timeline for completion by October 2025.

3 ARTICLES

3w ago

Novo Nordisk Partners with Septerna in $2.2 Billion Deal for Oral Obesity Therapies

3 ARTICLES

last mo.

Lotte Biologics Secures First ADC Manufacturing Deal, Launches Full-Scale Operations

3 ARTICLES

2mo ago

Moderna Secures $590M U.S. Grant to Advance Bird Flu Vaccine Development

Biotechnology

Samsung Biologics Announces Spin-Off of Biosimilar Unit to Form Samsung Epis Holdings

Novo Nordisk Partners with Septerna in $2.2 Billion Deal for Oral Obesity Therapies

Lotte Biologics Secures First ADC Manufacturing Deal, Launches Full-Scale Operations

Biogen Announces Move to New Headquarters in Kendall Common

Cargo Therapeutics Ceases Operations Following Clinical and Financial Setbacks

AstraZeneca Acquires Belgian Biotech EsoBiotec in $1 Billion Deal

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

23andMe Explores Strategic Options as Financial Struggles Deepen

Moderna Secures $590M U.S. Grant to Advance Bird Flu Vaccine Development